ESGCT – 2024 – Oral Presentation OR085
Publications
October 24, 2024
Novel CD33/CLL-1-directed dual CAR-T cells mediate potent antigen-specific cytolytic activity in mouse models of Acute Myeloid Leukemia (AML)
CD33-CLL1 Treatment System
Presented by: Mariana Silva, PhD – Cancer Immunotherapy – Vor Bio